ARTUS THERAPEUTICS INC.
Allston, MA · Biotech · Private
Small molecule therapeutics (ARTX-2) that enhance lung barrier function by upregulating tight and adherens junction proteins in respiratory epithelium and endothelium
- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · First-in-class small molecules that enhance lung barrier function during acute respiratory distress syndrome (ARDS) as potential therapeutics for COVID-19 | $249,998 | |
| Federal grant | Department of Health and Human Services · Phase I · First-in-class small molecule therapeutics to enhance gut barrier function in inflammatory bowel disease | $251,191 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · First-in-class small molecule therapeutics to enhance gut barrier function in inflammatory bowel disease | $251,191 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · First-in-class small molecules that enhance lung barrier function during acute respiratory distress syndrome (ARDS) as potential therapeutics for COVID-19 | $249,998 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1365 | ADECTO PHARMACEUTICALS, INC. | — | — |
| 1366 | WEATHERWAX BIOTECHNOLOGIES CORPORATION | — | — |
| 1367 | NANO BIOTHERAPEUTICS INC | — | — |
| 1368 | ARTUS THERAPEUTICS INC. | — | — |
| 1369 | Curebiotech, Inc. | — | — |
| 1370 | BOUND THERAPEUTICS LLC | — | — |
| 1371 | BioHybrid Solutions LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Therapeutic Agents For Enhancing Epithelial And/or Endothelial Barrier Functionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.